Amdocs Limited Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2025: 15.59%

Amdocs Limited Return on Equity (ROE) is 15.59% for the Trailing 12 Months (TTM) ending March 31, 2025, a 5.08% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Amdocs Limited Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2024 was 14.83%, a -2.01% change year over year.
  • Amdocs Limited Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2023 was 15.14%, a -3.54% change year over year.
  • Amdocs Limited Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2022 was 15.69%, a -14.63% change year over year.
  • Amdocs Limited Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 31, 2021 was 18.38%, a 30.16% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share